RVV — Revive Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Revive Therapeutics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.92	2.09	0.773	0.015	0.005
Net Total Receivables	0.191	0.157	0.021	0	0.088
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.16	2.35	1.14	0.068	0.151
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.002	0.001	0.001	0.001	0.001
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	17.1	14.3	10.6	0.205	0.283
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	4.17	3.44	3.32	3.51	4.22
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.46	3.6	3.4	3.66	4.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	12.6	10.7	7.23	-3.46	-4.02
Total Liabilities & Shareholders' Equity	17.1	14.3	10.6	0.205	0.283
Total Common Shares Outstanding